Cargando…

N-Acetylcysteine Reverses the Mitochondrial Dysfunction Induced by Very Long-Chain Fatty Acids in Murine Oligodendrocyte Model of Adrenoleukodystrophy

The accumulation of saturated very long-chain fatty acids (VLCFA, ≥C22:0) due to peroxisomal impairment leads to oxidative stress and neurodegeneration in X-linked adrenoleukodystrophy (ALD). Among the neural supporting cells, myelin-producing oligodendrocytes are the most sensitive to the detriment...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jie, Terluk, Marcia R., Orchard, Paul J., Cloyd, James C., Kartha, Reena V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698433/
https://www.ncbi.nlm.nih.gov/pubmed/34944641
http://dx.doi.org/10.3390/biomedicines9121826
_version_ 1784620278608822272
author Zhou, Jie
Terluk, Marcia R.
Orchard, Paul J.
Cloyd, James C.
Kartha, Reena V.
author_facet Zhou, Jie
Terluk, Marcia R.
Orchard, Paul J.
Cloyd, James C.
Kartha, Reena V.
author_sort Zhou, Jie
collection PubMed
description The accumulation of saturated very long-chain fatty acids (VLCFA, ≥C22:0) due to peroxisomal impairment leads to oxidative stress and neurodegeneration in X-linked adrenoleukodystrophy (ALD). Among the neural supporting cells, myelin-producing oligodendrocytes are the most sensitive to the detrimental effect of VLCFA. Here, we characterized the mitochondrial dysfunction and cell death induced by VLFCA, and examined whether N-acetylcysteine (NAC), an antioxidant, prevents the cytotoxicity. We exposed murine oligodendrocytes (158 N) to hexacosanoic acid (C26:0, 1–100 µM) for 24 h and measured reactive oxygen species (ROS) and cell death. Low concentrations of C26:0 (≤25 µM) induced a mild effect on cell survival with no alterations in ROS or total glutathione (GSH) concentrations. However, analysis of the mitochondrial status of cells treated with C26:0 (25 µM) revealed depletion in mitochondrial GSH (mtGSH) and a decrease in the inner membrane potential. These results indicate that VLCFA disturbs the mitochondrial membrane potential causing ROS accumulation, oxidative stress, and cell death. We further tested whether NAC (500 µM) can prevent the mitochondria-specific effects of VLCFA in C26:0-treated oligodendrocytes. Our results demonstrate that NAC improves mtGSH levels and mitochondrial function in oligodendrocytes, indicating that it has potential use in the treatment of ALD and related disorders.
format Online
Article
Text
id pubmed-8698433
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86984332021-12-24 N-Acetylcysteine Reverses the Mitochondrial Dysfunction Induced by Very Long-Chain Fatty Acids in Murine Oligodendrocyte Model of Adrenoleukodystrophy Zhou, Jie Terluk, Marcia R. Orchard, Paul J. Cloyd, James C. Kartha, Reena V. Biomedicines Article The accumulation of saturated very long-chain fatty acids (VLCFA, ≥C22:0) due to peroxisomal impairment leads to oxidative stress and neurodegeneration in X-linked adrenoleukodystrophy (ALD). Among the neural supporting cells, myelin-producing oligodendrocytes are the most sensitive to the detrimental effect of VLCFA. Here, we characterized the mitochondrial dysfunction and cell death induced by VLFCA, and examined whether N-acetylcysteine (NAC), an antioxidant, prevents the cytotoxicity. We exposed murine oligodendrocytes (158 N) to hexacosanoic acid (C26:0, 1–100 µM) for 24 h and measured reactive oxygen species (ROS) and cell death. Low concentrations of C26:0 (≤25 µM) induced a mild effect on cell survival with no alterations in ROS or total glutathione (GSH) concentrations. However, analysis of the mitochondrial status of cells treated with C26:0 (25 µM) revealed depletion in mitochondrial GSH (mtGSH) and a decrease in the inner membrane potential. These results indicate that VLCFA disturbs the mitochondrial membrane potential causing ROS accumulation, oxidative stress, and cell death. We further tested whether NAC (500 µM) can prevent the mitochondria-specific effects of VLCFA in C26:0-treated oligodendrocytes. Our results demonstrate that NAC improves mtGSH levels and mitochondrial function in oligodendrocytes, indicating that it has potential use in the treatment of ALD and related disorders. MDPI 2021-12-03 /pmc/articles/PMC8698433/ /pubmed/34944641 http://dx.doi.org/10.3390/biomedicines9121826 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zhou, Jie
Terluk, Marcia R.
Orchard, Paul J.
Cloyd, James C.
Kartha, Reena V.
N-Acetylcysteine Reverses the Mitochondrial Dysfunction Induced by Very Long-Chain Fatty Acids in Murine Oligodendrocyte Model of Adrenoleukodystrophy
title N-Acetylcysteine Reverses the Mitochondrial Dysfunction Induced by Very Long-Chain Fatty Acids in Murine Oligodendrocyte Model of Adrenoleukodystrophy
title_full N-Acetylcysteine Reverses the Mitochondrial Dysfunction Induced by Very Long-Chain Fatty Acids in Murine Oligodendrocyte Model of Adrenoleukodystrophy
title_fullStr N-Acetylcysteine Reverses the Mitochondrial Dysfunction Induced by Very Long-Chain Fatty Acids in Murine Oligodendrocyte Model of Adrenoleukodystrophy
title_full_unstemmed N-Acetylcysteine Reverses the Mitochondrial Dysfunction Induced by Very Long-Chain Fatty Acids in Murine Oligodendrocyte Model of Adrenoleukodystrophy
title_short N-Acetylcysteine Reverses the Mitochondrial Dysfunction Induced by Very Long-Chain Fatty Acids in Murine Oligodendrocyte Model of Adrenoleukodystrophy
title_sort n-acetylcysteine reverses the mitochondrial dysfunction induced by very long-chain fatty acids in murine oligodendrocyte model of adrenoleukodystrophy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698433/
https://www.ncbi.nlm.nih.gov/pubmed/34944641
http://dx.doi.org/10.3390/biomedicines9121826
work_keys_str_mv AT zhoujie nacetylcysteinereversesthemitochondrialdysfunctioninducedbyverylongchainfattyacidsinmurineoligodendrocytemodelofadrenoleukodystrophy
AT terlukmarciar nacetylcysteinereversesthemitochondrialdysfunctioninducedbyverylongchainfattyacidsinmurineoligodendrocytemodelofadrenoleukodystrophy
AT orchardpaulj nacetylcysteinereversesthemitochondrialdysfunctioninducedbyverylongchainfattyacidsinmurineoligodendrocytemodelofadrenoleukodystrophy
AT cloydjamesc nacetylcysteinereversesthemitochondrialdysfunctioninducedbyverylongchainfattyacidsinmurineoligodendrocytemodelofadrenoleukodystrophy
AT karthareenav nacetylcysteinereversesthemitochondrialdysfunctioninducedbyverylongchainfattyacidsinmurineoligodendrocytemodelofadrenoleukodystrophy